Crossmark

Prognostic significance of serum interleukin-6 in severe/critical COVID-19 patients treated with tocilizumab: a detailed observational study analysis

Published Online: 2024-11-28

Authors

Liang, Panpan

Li, Yan

Meng, Li’e

Li, Yuting

Mai, Hailing

Li, Tao

Ma, Jiarui

Ma, Junhui

Wang, Jing

Zhuan, Bing

Zhou, Wei
License Information

Text and Data Mining valid from 2024-11-28

Version of Record valid from 2024-11-28
More Information

Article History

Received: 25 June 2024

Accepted: 25 November 2024

First Online: 28 November 2024

Competing interests

: The authors declare no competing interests.

Document is current